Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma

Molecular and Cellular Biology

Volumn 23, Issue 7, 2003, Pages 2225-2238

  Baldassarre, Gustavo ^a,d   Battista, Sabrina ^a,b   Belletti, Barbara ^a,d   Thakur, Sanjay ^a   Pentimalli, Francesca ^a,b   Trapasso, Francesco ^a   Fedele, Monica ^b   Pierantoni, Giovanna ^b   Croce, Carlo M ^a   Fusco, Alfredo ^b,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Faculta di Med e Chir di Napoli   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; ESTROGEN; HIGH MOBILITY GROUP A PROTEIN; MESSENGER RNA;

ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOMA; CELL LINE; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENES, REPORTER; HMGA1B PROTEIN; HUMANS; MICE; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA, MESSENGER; S PHASE; STEM CELLS; TRANSFECTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS; MURINAE;

EID: 0037377764     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.7.2225-2238.2003     Document Type: Article

References (53)

1. Abe, N., T. Watanabe, M. Sugiyama, H. Uchimura, G. Chiappetta, A. Fusco, and Y. Atomi. 1999. Determination of high mobility group I(Y) expression level in colorectal neoplasias: a potential diagnostic marker. Cancer Res. 59:1169-1174.
2. Abe, N., T. Watanabe, T. Masaki, T. Mori, M. Sugiyama, H. Uchimura, Y. Fujioka, G. Chiappetta, A. Fusco, and Y. Atomi. 2000. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res. 60:3117-3122.
3. Baldassarre, G., M. V. Barone, B. Belletti, C. Sandomenico, P. Bruni, S. Spiezia, A. Boccia, M. T. Vento, A. Romano, S. Pepe, A. Fusco, and G. Viglietto. 1999. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. Oncogene 18:6241-6251.
4. Baldassarre, G., M. Fedele, S. Battista, A. Vecchione, A. J. Klein-Szanto, M. Santoro, T. A. Waldmann, N. Azimi, C. M. Croce, and A. Fusco. 2001. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc. Natl. Acad. Sci. USA 98:7970-7975.
5. Bandiera, A., D. Bonifacio, G. Manfioletti, F. Mantovani, A. Rustighi, F. Zanconati, A. Fusco, L. Di Bonito, and V. Giancotti. 1998. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res. 58:426-431.
6. Berlingieri, M. T., G. Manfioletti, M. Santoro, A. Bandiera, R. Visconti, V. Giancotti, and A. Fusco. 1995. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol. 15:1545-1553.
7. Bernard-Gallon, D. J., M. P. De Latour, P. G. Rio, F. M. Penault-Llorca, D. A. Favy, C. Hizel, J. Chassagne, and Y. J. Bignon. 1999. Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene. Int. J. Oncol. 14:653-661.
8. Bennett, L. M., H. A. Brownlee, S. Hagavik, and R. W. Wiseman. 1999. Sequence analysis of the rat Brca1 homolog and its promoter region. Mamm. Genome 10:19-25.
9. Bianco, T., G. Chenevix-Trench, D. C. Walsh, J. E. Cooper, and A. Dobrovic. 2000. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21:147-151.
10. Braunstein, M., A. B. Rose, S. G. Holmes, C. D. Allis, and J. R. Broach. 1993. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev. 7:592-604.
11. Catteau, A., W. H. Harris, C. F. Xu, and E. Solomon. 1999. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18:1957-1965.
12. Chiappetta, G., V. Avantaggiato, R. Visconti, M. Fedele, S. Battista, F. Trapasso, B. M. Merciai, V. Fidanza, V. Giancotti, M. Santoro, A. Simeone, A. Fusco. 1996. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13:2439-2446.
13. Chiappetta, G., G. Tallini, M. C. De Biasio, G. Manfioletti, F. J. Martinez-Tello, F. Pentimalli, F. de Nigris, A. Mastro, G. Botti, M. Fedele, N. Berger, M. Santoro, V. Giancotti, and A. Fusco. 1998. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res. 58:4193-4198.
14. Chiappetta, G., G. Manfioletti, F. Pentimalli, N. Abe, M. Di Bonito, M. T. Vento, A. Giuliano, M. Fedele, G. Viglietto, M. Santoro, T. Watanabe, V. Giancotti, and A. Fusco. 2001. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases. Int. J. Cancer. 91:147-151.
15. Chiappetta, G., A. Bandiera, M. T. Berlingieri, R. Visconti, G. Manfioletti, S. Battista, F. J. Martinez-Tello, M. Santoro, V. Giancotti, and A. Fusco. 1995. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10:1307-1314.
16. Dobrovic, A., and D. Simpfendorfer. 1997. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 57:3347-3350.
17. Fan, S., J. Wang, R. Yuan, Y. Ma, Q. Meng, M. R. Erdos, R. G. Pestell, F. Yuan, K. J. Auborn, I. D. Goldberg, and E. M. Rosen. 1999. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284:1354-1356.
18. Fan, S., Y. X. Ma, C. Wang, R. Q. Yuan, Q. Meng, J. A. Wang, M. Erdos, I. D. Goldberg, P. Webb, P. J. Kushner, R. G. Pestell, and E. M. Rosen. 2001. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene 20:77-87.
19. Fedele, M., A. Bandiera, G. Chiappetta, S. Battista, G. Viglietto, G. Manfioletti, A. Casamassimi, M. Santoro, V. Giancotti, and A. Fusco. 1996. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res. 56:1896-1901.
20. Fedele, M., G. M. Pierantoni, M. T. Berlingieri, S. Battista, G. Baldassarre, N. Munshi, M. Dentice, D. Thanos, M. Santoro, G. Viglietto, and A. Fusco. 2001. Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. Cancer Res. 61:4583-4590.
21. Futreal, P. A., Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. M. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki, et al. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122.
22. Gudas, J. M., H. Nguyen, T. Li., and K. H. Cowan. 1995. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res. 55:4561-4565.
23. Gudas, J. M., T. Li, H. Nguyen, D. Jensen, F. J. Rauscher, and K. H. Cowan. 1996. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Cell Growth Differ. 7:717-723.
24. Hartman, A. R., and J. M. Ford. 2002. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat. Gen. 32:180-184.
25. Hilakivi-Clarke, L. 2000. Estrogens, BRCA1, and breast cancer. Cancer Res. 60:4993-5001.
26. Jarvis, E. M., J. A. Kirk, and C. L. Clarke. 1998. Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype. Cancer Genet. Cytogenet. 101:109-115.
27. Kinzler, K., and B. Vogelstein. 1997. Gatekeepers and caretakers. Nature 386:761-763.
28. Liu, W. M., F. K. Guerra-Vladusic, S. Kurakata, R. Lupu, and T. Kohwi-Shigematsu. 1999. HMG-I(Y) recognizes base-unpairing regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype. Cancer Res. 59:5695-5703.
29. Magdinier, F., S. Ribieras, G. M. Lenoir, L. Frappart, and R. Dante. 1998. Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter region. Oncogene 17:3169-3176.
30. Marquis, S. T., J. V. Rajan, A. Wynshaw-Boris, J. Xu, G. Y. Yin, K. J. Abel, B. L. Weber, and L. A. Chodosh. 1995. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat. Genet. 11:17-26.
31. Miki, Y., J. Swensen, D. Shattuck-Eidens, P. A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L. M. Bennett, W. Ding, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
32. Orlando, V. 2000. Mapping chromosomal proteins in vivo by formaldehydecrosslinked-chromatin immunoprecipitation. Trends Biochem. Sci. 25:99-104.
33. Ram, T. G., R. Reeves, and H. L. Hosick. 1993. Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res. 53:2655-2660.
34. Reeves, R., D. D. Edberg, and Y. Li. 2001. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 21:575-594.
35. Reeves, R., and L. Beckerbauer. 2001. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta 1519:13-29.
36. Rice, J. C., H. Ozcelik, P. Maxeiner, I. Andrulis, and B. W. Futscher. 2000. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens. Carcinogenesis 21:1761-1765.
37. Rio, P. G., J. C. Maurizis, M. Peffault de Latour, Y. J. Bignon, and D. J. Bernard-Gallon. 1999. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int. J. Cancer 80:823-826.
38. Romagnolo, D., L. A. Annab, T. E. Thompson, J. I. Risinger, L. A. Terry, J. C. Barrett, and C. A. Afshari. 1998. Estrogen upregulation of BRCA1 expression with no effect on localization. Mol. Carcinog. 22:102-109.
39. Ruffner, H., and I. M. Verma. 1997. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. Natl. Acad. Sci. USA 94:7138-7143.
40. Russell, P. A., P. D. Pharoah, K. De Foy, S. J. Ramus, I. Symmonds, A. Wilson, I. Scott, B. A. Ponder, and S. A. Gayther. 2000. Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. Int. J. Cancer 87:317-321.
41. Scala, S., G. Portella, M. Fedele, G. Chiappetta, and A. Fusco. 2000. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proc. Natl. Acad. Sci. USA 97:4256-4261.
42. Schafer, J. M., E. S. Lee, R. M. O'Regan, K. Yao, and V. C. Jordan. 2000. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice. Clin. Cancer Res. 6:4373-4380.
43. Scully, R., and D. L. Livingston. 2000. In search of the tumor suppressor function of BRCA1 and BRCA2. Nature 408:429-432.
44. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteoporosis in mice. Cell 64:693-702.
45. Sourvinos, G., and D. A. Spandidos. 1998. Decreased BRCA1 expression may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors. Biochem. Biophys. Res. Comm. 245:75-80.
46. Tamimi, Y., H. G. van der Poel, M. M. Denyn, R. Umbas, H. F. Karthaus, F. M. Debruyne, and J. A. Schalken. 1993. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res. 3:5512-5516.
47. Thakur, S., H. B. Zhang, Y. Peng, H. Le, B. Carroll, T. Ward, J. Yao, L. M. Farid, F. J. Couch, R. B. Wilson, and B. L. Weber. 1997. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol. Cell. Biol. 17:444-452.
48. Thakur, S., and C. M. Croce. 1999. Positive regulation of the BRCA1 promoter. J. Biol. Chem. 274:8837-8843.
49. Thompson, M. E., R. A. Jensen, P. S. Obermiller, D. L. Page, and J. T. Holt. 1995. Decreased expression of BRCA1 accelerates growth, and is often present during sporadic breast cancer progression. Nat. Genet. 9:444-450.
50. Vaughn, J. P., P. L. Davis, M. D. Jarboe, G. Huper, A. C. Evans, R. W. Wiseman, A. Berchuck, J. D. Iglehart P. A. Futreal, and J. R. Marks. 1996. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ. 7:711-715.
51. Wilson, C. A., L. Ramos, M. R. Villaseñor, K. H. Anders, M. F. Press, K. Clarke, B. Karlan, J. J. Chen, R. Scully, D. Livingston, R. H. Zuch, M. H. Kanter, S. Cohen, F. J. Calzone, and D. J. Slamon. 1999. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Gen. 21:236-240.
52. Yoshikawa, K., K. Honda, T. Inamoto, H. Shinohara, A. Yamauchi, K. Suga, T. Okuyama, T. Shimada, H. Kodama, S. Noguchi, A. F. Gazdar, Y. Yamaoka, and R. Takahashi. 1999. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss inBRCA1-associated cases. Clin. Cancer Res. 5:1249-1261.
53. Zhou, X., K. F. Benson, H. R. Ashar, and K. Chada. 1995. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376:771-774.